BridgeMD
Tests treatment safety and results for Healthy Volunteers
Official title A Study to Assess the Safety of ARGX-124 in Healthy Volunteers
ClinicalTrials.gov ID: NCT07377396
What this study is testing
What is ARGX-124?
ARGX-124 is an investigational medicine, being studied as a potential treatment for healthy volunteers.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study aims to assess the safety of ARGX-124 in healthy adults. Another aim is to measure the amount of ARGX-124 in the blood over time to learn how it acts and moves in the body and how the immune system responds to it.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65. Healthy volunteers may be eligible.
You may be able to join if
- Is at least the local legal age of consent and aged 18 to 65 years, inclusive, when signing the ICF.
- Is a female of Nonchildbearing Potential (postmenopausal or surgically sterilized) or a male.
- Has a body weight between 50 and 120 kg and a BMI between 18 and 30.5 kg/m2, inclusive.
You likely can't join if
- Has any current or past clinically meaningful medical or psychiatric condition that, in the investigator's opinion, would confound the study results...
- Has IgG levels \<6.0 g/L at screening.
- Has a history of an immunosuppressive disease or an immunosuppressive condition at screening.
- Previously participated in an ARGX-124, ARGX-213, or efgartigimod clinical study and received at least 1 dose of the study drug.
The study team makes the final eligibility decision.
Where it's taking place
- Montreal, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montreal, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.